ResearcherRutgers, The State University of New JerseyActive in the last 2 years

Tamara Minko

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1633-4705; OpenAlex author ID A5084229113. Sources: OpenAlex.

Their work

Papers: 3 (first author 1, last author 1)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 1

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 2 papers

Papers 3

Targeted Nanoparticle-Based Diagnostic and Treatment Options for Pancreatic Cancer. First author DOI 10.3390/cancers16081589 ↗
Nanotechnology-Based Strategy for Enhancing Therapeutic Efficacy in Pancreatic Cancer: Receptor-Targeted Drug Delivery by Somatostatin Analog. Last author DOI 10.3390/ijms25105545 ↗
Nanoformulation of BRD4-Degrading PROTAC: Improving Druggability To Target the 'Undruggable' MYC in Pancreatic Cancer. Co-author DOI 10.1016/j.tips.2020.08.008 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xin Gu · 2 shared papers, 2024 · strength 0.70
- Paper Targeted Nanoparticle-Based Diagnostic and Treatment Options for Pancreatic Cancer. DOI 10.3390/cancers16081589 ↗
- Paper Nanotechnology-Based Strategy for Enhancing Therapeutic Efficacy in Pancreatic Cancer: Receptor-Targeted Drug Delivery … DOI 10.3390/ijms25105545 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.